Jeena Sikho Lifecare Quarterly Results for Trading Insights
In Mar 2026, Jeena Sikho Lifecare (JSLL) reported revenue ₹219 Cr and net profit ₹45 Cr — revenue +56.4% YoY. Browse Jeena Sikho Lifecare annual reports for revenue, profit, balance sheet and cash flow data.
JSLL Quarterly Results — Revenue, Profit & EPS Highlights
Jeena Sikho Lifecare latest quarter revenue, net profit, EPS and QoQ/YoY growth rates. Also explore JSLL share price data to track price trends across different timeframes.
- Revenue of ₹219 Cr in Mar 2026 (-8.4% vs Jun 2026, +56.4% vs Mar 2025)
- Net Profit of ₹45 Cr in Mar 2026 (-31.8% vs Jun 2026, +80.0% vs Mar 2025)
- EBITDA of ₹81 Cr in Mar 2026 (-23.6% vs Jun 2026)
- Operating Margin of 36.0% in Mar 2026 (-5.0pp vs Jun 2026)
- Earnings Per Share of ₹3.63 in Mar 2026 (-31.5% vs Jun 2026)
Jeena Sikho Lifecare Quarterly Results — Revenue, EBITDA, Net Profit & EPS
JSLL quarterly revenue, expenses, EBITDA, net profit, EPS and operating margin with QoQ and YoY comparison.
| Metric | Mar 2026 | Jun 2026 | Sept 2025 | Mar 2025 | Jun 2025 | QoQ | YoY |
|---|---|---|---|---|---|---|---|
| Revenue (₹ Cr) | 219 | 239 | 191 | 140 | 175 | -8.4% | 56.4% |
| Net Profit (₹ Cr) | 45 | 66 | 59 | 25 | 51 | - | - |
| EBITDA (₹ Cr) | 81 | 106 | 94 | 46 | 80 | - | - |
| EPS (₹) | 3.63 | 5.30 | 4.73 | 2.04 | 4.12 | - | - |
| Operating Margin (%) | 36.0% | 41.0% | 48.0% | 33.0% | 45.0% | - | - |
JSLL Share Price Trend — 1-Year Movement Across Quarterly Results
Jeena Sikho Lifecare 1-year share price in ₹ overlaid with quarterly earnings dates — NSE/BSE closing prices. For annual financials, live price and key ratios, visit Jeena Sikho Lifecare stock price NSE.
Revenue Trend (₹ Cr)
Net Profit Trend (₹ Cr)
Operating Margin Trend (%)
JSLL vs Healthcare Peers — Quarterly Revenue, Profit & Market Cap
Jeena Sikho Lifecare latest quarter revenue and net profit vs Healthcare competitors — market cap, price and earnings comparison.
| Company Latest Quarter | Market Cap (₹ Cr) | Price (₹) | Revenue (₹ Cr) | Net Profit (₹ Cr) | Rev QoQ % | Rev YoY % | Profit Margin % | P/E Ratio |
|---|---|---|---|---|---|---|---|---|
|
Sun Pharmaceutical
Mar 2026 |
₹463,071.60 Cr | 1875.1 | 15,018 | 2,710 | -5.6% | - | 18.0% | 165.9 |
|
Divis Laboratories
Mar 2026 |
₹225,157.18 Cr | 8588.0 | 2,986 | 751 | -5.0% | - | 25.2% | 303.4 |
|
Torrent Pharmaceuti…
Mar 2026 |
₹188,719.51 Cr | 4971.0 | 4,111 | 364 | +27.7% | +42.2% | 8.9% | 431.9 |
|
Cipla
Mar 2026 |
₹117,137.57 Cr | 1431.1 | 6,612 | 543 | -9.3% | - | 8.2% | 208.3 |
|
Zydus Life Science
Mar 2026 |
₹113,855.38 Cr | 1115.6 | 7,569 | 1,341 | -4.3% | - | 17.7% | 88.2 |
All amounts in ₹ Crores